AG00G3OH

850664-21-0 | GSK269962A

850664-21-0
AG00G3OH
sdsSDS
sdsCOA
TIP This product is typically in stock.Please contact us for quotation.
Request For Quotation

CAS Number 850664-21-0
Catalog Number AG00G3OH(AGN-PC-00SXRU)
Chemical Name GSK269962A
IUPAC Name N-[3-[2-(4-amino-1,2,5-oxadiazol-3-yl)-1-ethylimidazo[4,5-c]pyridin-6-yl]oxyphenyl]-4-(2-morpholin-4-ylethoxy)benzamide
InChI InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)
InChI Key YOVNFNXUCOWYSG-UHFFFAOYSA-N
MDL Number MFCD09970310
Molecular Formula C29H30N8O5
Molecular Weight 570.5991
SMILES O=C(NC1=CC=CC(OC2=CC3=C(N=C(C4=NON=C4N)N3CC)C=N2)=C1)C5=CC=C(OCCN6CCOCC6)C=C5
Synonyms
GSK 269962A, GSK-269962A, GSK269962A, N-(3-((2-(4-amino-1,2,5-oxadiazol-3-yl)-1-ethyl-1H-imidazo(4,5-c)pyridin-6-yl)oxy)phenyl)-4-((2-(4-morpholinyl)ethyl)oxy)benzamide, GSK269962A, 850664-21-0, GSK 269962, GSK269962, GSK 269962A, GSK-269962A, Aminofurazanyl-azabenzimidazole 6n, 925213-63-4, GSK-269962, N-(3-{[2-(4-amino-1,2,5-oxadiazol-3-yl)-1-ethyl-1H-imidazo[4,5-c]pyridin-6-yl]oxy}phenyl)-4-[2-(morpholin-4-yl)ethoxy]benzamide, GSK269962A HCl, Kinome_3843, GSK269962A(GSK269962), MLS006010261, CHEMBL220241, GTPL8037, SCHEMBL1838346, BDBM14047, DTXSID40582496, EX-A674, YOVNFNXUCOWYSG-UHFFFAOYSA-N, C29H30N8O5, BCP27824, 3703AH, ABP000268, MFCD09970310, ZINC14954335, AKOS024457925, BCP9000742, CS-2790, NCGC00241982-01, NCGC00241982-03, AK547999, BC600782, HY-15556, SMR004701334, GSK269962A/GSK 269962A, GSK269962; GSK269962A, LS-193319, FT-0700376, A12348, AB01092223-01, GSK 269962A;GSK-269962A;GSK269962;GSK 269962;GSK-269962, N-(3-{[2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethyl-1H-imidazo[4,5-c] pyridin-6-yl]oxy}phenyl)-4-[2-(4-morpholinyl)ethoxy]benzamide, N-(3-{[2-(4-amino-furazan-3-yl)-1-ethyl-1H-imidazo[4,5-c]pyridin-6-yl]oxy}phenyl)-4-{[2-(4-morpholinyl)ethyl]oxy}benzamide, N-[3-[[2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethyl-1H-imidazo[4,5-c]pyridin-6-yl]oxy]phenyl]-4-[2-(4-morpholinyl)ethoxy]-benzamide, N-[3-[[2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethyl-1H-imidazo[4,5-c]pyridin-6-yl]oxy]phenyl]-4-[2-(4-morpholinyl)ethoxy]benzamide, N-[3-[2-(4-amino-1,2,5-oxadiazol-3-yl)-1-ethylimidazo[4,5-c]pyridin-6-yl]oxyphenyl]-4-(2-morpholin-4-ylethoxy)benzamide, N-[3-[2-(4-amino-1,2,5-oxadiazol-3-yl)-1-ethylimidazo[5,4-d]pyridin-6-yl]oxyphenyl]-4-(2-morpholin-4-ylethoxy)benzamide, N-{3-[2-(4-Amino-furazan-3-yl)-1-ethyl-1H-imidazo[4,5-c]pyridin-6-yloxy]-phenyl}-4-(2-morpholin-4-yl-ethoxy)-benzamide, D02ZQS, GSK269962B, 168828-81-7,

Product Recommendations

CERTIFICATE OF ANALYSIS
Chemical Name: Batch Number:
Chemical Structure: CAS Registry No:
Product ID:
Manufacture Date:
Storage Temperature:
Formula:
Molecular Weight:
Quantity:
Analysis Data:
Test: Result:
Conclusion: The above product meets the specifications of Angene.
Analyst:Chase
Date:
Reviewed by:Jessie
Date:
Angene International Limited